Walker Mary W, Wolinsky Toni D, Jubian Vrej, Chandrasena Gamini, Zhong Huailing, Huang Xinyan, Miller Silke, Hegde Laxminarayan G, Marsteller Douglas A, Marzabadi Mohammad R, Papp Mariusz, Overstreet David H, Gerald Christophe P G, Craig Douglas A
Lundbeck Research USA, 215 College Road, Paramus, NJ 07652, USA.
J Pharmacol Exp Ther. 2009 Mar;328(3):900-11. doi: 10.1124/jpet.108.144634. Epub 2008 Dec 19.
Neuropeptide Y (NPY) regulates physiological processes via receptor subtypes (Y(1), Y(2), Y(4), Y(5), and y(6)). The Y(5) receptor is well known for its role in appetite. Based on expression in the limbic system, we hypothesized that the Y(5) receptor might also modulate stress sensitivity. We identified a novel Y(5) receptor-selective antagonist, Lu AA33810 [N-[[trans-4-[(4,5-dihydro[1]-benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-methanesulfonamide], that bound to cloned rat Y(5) receptors (K(i) = 1.5 nM) and antagonized NPY-evoked cAMP and calcium mobilization in vitro. Lu AA33810 (3-30 mg/kg p.o.) blocked feeding elicited by intracerebroventricular injection of the Y(5) receptor-selective agonist [cPP(1-7),NPY(19-23),Ala(31),Aib(32),Gln(34)]-hPancreatic Polypeptide in Sprague-Dawley rats. In vivo effects of Lu AA33810 were correlated with brain exposure > or = 50 ng/g and ex vivo Y(5) receptor occupancy of 22 to 95%. Lu AA33810 was subsequently evaluated in models of stress sensitivity. In Fischer 344 rats, Lu AA33810 (30 mg/kg p.o.) attenuated increases in plasma ACTH and corticosterone elicited by intracerebroventricular injection of [cPP(1-7),NPY(19-23),Ala(31),Aib(32),Gln(34)]-hPancreatic Polypeptide. In Sprague-Dawley rats subjected to the social interaction test, Lu AA33810 (3-30 mg/kg p.o.) produced anxiolytic-like effects after acute or chronic treatment. In Flinders sensitive line rats, chronic dosing of Lu AA33810 (10 mg/kg/day i.p.) produced anxiolytic-like effects in the social interaction test, plus antidepressant-like effects in the forced swim test. In Wistar rats exposed to chronic mild stress, chronic dosing of Lu AA33810 (3 and 10 mg/kg/day i.p.) produced antidepressant-like activity, i.e., normalization of stress-induced decrease in sucrose consumption. We propose that Y(5) receptors may function as part of an endogenous stress-sensing system to mediate social anxiety and reward or motivational deficits in selected rodent models.
神经肽Y(NPY)通过受体亚型(Y(1)、Y(2)、Y(4)、Y(5)和Y(6))调节生理过程。Y(5)受体因其在食欲方面的作用而广为人知。基于其在边缘系统中的表达,我们推测Y(5)受体可能也会调节应激敏感性。我们鉴定出一种新型的Y(5)受体选择性拮抗剂Lu AA33810 [N-[[反式-4-[(4,5-二氢[1]-苯并硫氮杂䓬并[5,4-d]噻唑-2-基)氨基]环己基]甲基]-甲磺酰胺],它与克隆的大鼠Y(5)受体结合(K(i)=1.5 nM),并在体外拮抗NPY诱导的环磷酸腺苷(cAMP)和钙动员。Lu AA33810(口服3 - 30 mg/kg)可阻断在Sprague-Dawley大鼠中脑室内注射Y(5)受体选择性激动剂[cPP(1 - 7),NPY(19 - 23),Ala(31),Aib(32),Gln(34)]-人胰多肽所引发的进食。Lu AA33810的体内效应与脑暴露量≥50 ng/g以及体外Y(5)受体占有率22%至95%相关。随后在应激敏感性模型中对Lu AA33810进行了评估。在Fischer 344大鼠中,Lu AA33810(口服30 mg/kg)可减弱脑室内注射[cPP(1 - 7),NPY(19 - 23),Ala(31),Aib(32),Gln(34)]-人胰多肽所引发的血浆促肾上腺皮质激素(ACTH)和皮质酮的升高。在接受社会互动测试的Sprague-Dawley大鼠中,急性或慢性给予Lu AA33810(口服3 - 30 mg/kg)会产生抗焦虑样效应。在Flinders敏感系大鼠中,慢性给予Lu AA33810(腹腔注射10 mg/kg/天)在社会互动测试中产生抗焦虑样效应,在强迫游泳测试中产生抗抑郁样效应。在暴露于慢性轻度应激的Wistar大鼠中,慢性给予Lu AA33810(腹腔注射3和10 mg/kg/天)产生抗抑郁样活性,即应激诱导的蔗糖消耗减少恢复正常。我们提出Y(5)受体可能作为内源性应激感知系统的一部分发挥作用,以介导特定啮齿动物模型中的社交焦虑以及奖赏或动机缺陷。